Aging
Navigate
Editorial|Volume 11, Issue 21|pp 9225—9226

CCL21 and prognosis in acute coronary syndrome

Thor Ueland1,3,4, Pål Aukrust1,2,3, Kenneth Caidahl5,6,7
  • 1Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
  • 2Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway
  • 3Faculty of Medicine, University of Oslo, Oslo, Norway
  • 4K.G. Jebsen-Thrombosis Research and Expertise Center (TREC), University of Tromsø, Tromsø, Norway
  • 5Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
  • 6Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden
  • 7Departments of Molecular Medicine and Surgery and Clinical Physiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
Received: September 17, 2019Accepted: October 3, 2019Published: November 6, 2019

Copyright © 2019 Ueland et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.